Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

indigo specialty products pty ltd - sulphonated aromatic acid dye - liquid - sulphonated aromatic acid dye dye active 90.0 g/l - marker - foam marker | pesticide additive - dye marker

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

bioproperties pty. ltd. - salmonella typhimurium - oral solution/suspension - salmonella typhimurium vaccine-microbial active 0.0 undefined - immunotherapy - poultry chicks | turkey poult (young) | chickens | day old chicks | hatchlings | turkeys - day old poults | young turkey - salmonella enteridis | salmonella typhimurium | vaccine | equine rotavirus

New Zealand - English - Medsafe (Medicines Safety Authority)

weleda (new zealand) ltd - alum 6 x (alumen chromicum 6 x); gelsemium sempervirens 6 x (decoction); potassium dichromate vi 6 x (kalium bichromicum 6 x); sabadilla 6 x - oral solution - active: alum 6 x (alumen chromicum 6 x) gelsemium sempervirens 6 x (decoction) potassium dichromate vi 6 x (kalium bichromicum 6 x) sabadilla 6 x excipient: ethanol

New Zealand - English - Medsafe (Medicines Safety Authority)

psm healthcare ltd trading as api consumer brands - chalk 25%{relative} - powder for oral suspension - 25% w/w - active: chalk 25%{relative}

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - lapatinib ditosilate monohydrate 405mg equivalent to 250 mg lapatinib free base - tablet - 250 mg - active: lapatinib ditosilate monohydrate 405mg equivalent to 250 mg lapatinib free base excipient: magnesium stearate microcrystalline cellulose opadry yellow ys-1-12524-a povidone sodium starch glycolate - her2-positive (her2+) overexpressing metastatic breast cancer tykerb, in combination with capecitabine, is indicated for the treatment of patients with advanced/metastatic breast cancer whose tumours overexpress her2 (erbb2) and whose tumours have progressed after treatment with an anthracycline and a taxane, and who have progressed on prior trastuzumab therapy in the metastatic setting. tykerb, in combination with paclitaxel, is indicated for the first-line treatment of patients with metastatic breast cancer whose tumours overexpress her2 (erbb2) and for whom trastuzumab is not appropriate. hormone receptor-positive metastatic breast cancer tykerb, in combination with an aromatase inhibitor, is indicated for the treatment of post-menopausal women with hormone receptor-positive metastatic breast cancer whose tumours overexpress her2 (erbb2) and for whom hormonal therapy is indicated.

Israel - English - Ministry of Health

rafa laboratories ltd - mesalazine - enema - mesalazine 4 g / 60 g - mesalazine - mesalazine - treatment and prevention of ulcerative colitis and crohn's disease.

Israel - English - Ministry of Health

rafa laboratories ltd - mesalazine - gastro resistant caplets - mesalazine 500 mg - mesalazine - mesalazine - treatment and prevention of ulcerative colitis and crohn's disease.

Israel - English - Ministry of Health

rafa laboratories ltd - mesalazine - suppositories - mesalazine 500 mg - mesalazine - mesalazine - treatment and prevention of ulcerative colitis and crohn's disease.

Israel - English - Ministry of Health

rafa laboratories ltd - mesalazine - gastro resistant caplets - mesalazine 1000.0 mg - mesalazine - mesalazine - treatment and prevention of ulcerative colitis and crohn's disease.

Israel - English - Ministry of Health

rafa laboratories ltd - mesalazine - suppositories - mesalazine 1000 mg - mesalazine - mesalazine - treatment and prevention of ulcerative colitis and crohn's disease.